Böttcher M F, Jenmalm M C, Voor T, Julge K, Holt P G, Björkstén B
Division of Pediatrics, Department of Molecular and Clinical Medicine, Linköping University, Linköping, Sweden.
Clin Exp Allergy. 2006 May;36(5):619-28. doi: 10.1111/j.1365-2222.2006.02484.x.
The prevalence of atopic disease among children in the formerly socialist countries in Europe, with a life style similar to that prevailing in Western Europe 30-40 years ago, is low, whereas there has been a pronounced increase in industrialized countries over the last decades. The environment during infancy influences the risk of developing allergy for many years, perhaps even for life.
To investigate the development of allergen-specific cytokine responses during the first 2 years of life in two geographically adjacent countries with marked differences in living conditions and incidence of atopic diseases, i.e. Estonia and Sweden.
The development of immune responses to food (beta-lactoglobulin (BLG) and ovalbumin (OVA)) and inhalant (cat and birch) allergens was studied from birth up to the age of 2 years in 30 Estonian and 76 Swedish infants. Clinical investigation and skin prick tests were performed and blood samples were obtained at birth and at 3, 6, 12 and 24 months.
The levels of IL-5, IL-10 and IL-13 secreted by peripheral blood mononuclear cells stimulated with BLG, OVA and cat allergen in Estonian and Swedish infants declined during the first 3 months of life. All cytokines then progressively increased in the Swedish infants, indicating the replacement of non-specifically responding immature cord blood T cells with specific T memory cells, which are primed postnatally. The resurgence of allergen-specific responses in the Estonian infants was less marked. These differences were particularly notable for birch-specific T cell responses, which correlated with development of atopic disease in the Swedish children.
The development of specific T cell memory to food and inhalant allergens during the first 2 years of life differs between infants living in Sweden and Estonia, and mirrors the disparate patterns of expression of allergic disease which subsequently develops in the respective populations.
在欧洲以前的社会主义国家中,儿童特应性疾病的患病率较低,其生活方式与30 - 40年前西欧盛行的生活方式相似,而在过去几十年里,工业化国家的患病率显著上升。婴儿期的环境会影响多年甚至可能一生发生过敏的风险。
在两个地理上相邻、生活条件和特应性疾病发病率有显著差异的国家,即爱沙尼亚和瑞典,研究生命最初2年中变应原特异性细胞因子反应的发展情况。
对30名爱沙尼亚婴儿和76名瑞典婴儿从出生到2岁进行了针对食物(β-乳球蛋白(BLG)和卵清蛋白(OVA))和吸入性(猫和桦树)变应原的免疫反应发展研究。进行了临床调查和皮肤点刺试验,并在出生时、3、6、12和24个月时采集血样。
爱沙尼亚和瑞典婴儿中,用BLG、OVA和猫变应原刺激外周血单个核细胞分泌的IL-5、IL-10和IL-13水平在生命的前3个月下降。然后,所有细胞因子在瑞典婴儿中逐渐增加,这表明非特异性反应的未成熟脐血T细胞被出生后致敏的特异性T记忆细胞所取代。爱沙尼亚婴儿中变应原特异性反应的复苏不太明显。这些差异在桦树特异性T细胞反应中尤为显著,这与瑞典儿童特应性疾病的发展相关。
瑞典和爱沙尼亚婴儿在生命最初2年中对食物和吸入性变应原的特异性T细胞记忆的发展有所不同,这反映了各自人群中随后发生的过敏性疾病的不同表达模式。